When calculating the total cost of a DOT drug testing program, which recurring operational cost is often underestimated by employers?
-
A
One-time policy development fees
-
B
Ongoing MRO review fees for negative results
-
C
Annual SAMHSA certification renewals
-
D
Equipment purchase for in-house testing